IGC Pharma Financial Overview
IGC Pharma's market cap is currently $32.29M. The company's EPS TTM is $-0.02; its P/E ratio is -4.29; IGC Pharma is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
